{"schema_version":"secwatch.filing_event.v1","accession":"0001803737-25-000163","form_type":"8-K","ticker":"EHAB","cik":"0001803737","company_name":"Enhabit, Inc.","filed_at":"2025-11-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.512164+00:00","generated_at":"2026-05-17T00:22:24.801424+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Enhabit Q3 revenue $263.6M (+3.9% YoY), Adj. EBITDA $27.0M, raises FY guidance midpoints","bullets":["Net income $11.1M vs loss of $110.2M; diluted EPS $0.22 (adj. EPS $0.17 vs $0.03).","Home health admissions +3.6% YoY; non-Medicare admissions +10.4%; hospice ADC +12.6%.","Hospice segment Adj. EBITDA $17.2M (+72% YoY); adjusted EBITDA margin 27.3%.","FY25 guidance: revenue $1,058-$1,063M, Adj. EBITDA $106-$109M, Adj. EPS $0.50-$0.56.","Reduced bank debt $15M in Q3; $100M reduction from Q4 2023; leverage ratio 3.9x."],"urls":{"canonical":"https://secwatch.observer/filing/0001803737-25-000163","json":"https://secwatch.observer/filing/0001803737-25-000163.json","markdown":"https://secwatch.observer/filing/0001803737-25-000163.md","text":"https://secwatch.observer/filing/0001803737-25-000163.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1803737/000180373725000163/0001803737-25-000163-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1803737/000180373725000163/ehab-20251105.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:22:24.801424+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}